These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37114131)

  • 1. Case report: High-risk acute promyelocytic leukemia and COVID-19-related myocarditis one patient, two cytokine storms.
    Ghiaur A; Doran C; Ionescu B; Mohorea-Neata LA; Stancioaica C; Hirjan R; Tatic A; Cirstea M; Vasilache D; Tabac D; Lupescu I; Coriu D
    Front Oncol; 2023; 13():1095154. PubMed ID: 37114131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Respiratory Distress Syndrome in a Patient With Acute Promyelocytic Leukemia: Overlapping Between Differentiation Syndrome and COVID-19.
    Sui J; Kelmenson D; Hu S; Cao L
    J Hematol; 2021 Oct; 10(5):217-220. PubMed ID: 34804311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute kidney failure in differentiation syndrome: a possible complication during therapy with differentiating agents for acute promyelocytic leukemia. A case report].
    Di Micco L; Mirenghi F; Morelli E; De Simone E
    G Ital Nefrol; 2019 Jul; 36(4):. PubMed ID: 31373469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
    De Botton S; Dombret H; Sanz M; Miguel JS; Caillot D; Zittoun R; Gardembas M; Stamatoulas A; Condé E; Guerci A; Gardin C; Geiser K; Makhoul DC; Reman O; de la Serna J; Lefrere F; Chomienne C; Chastang C; Degos L; Fenaux P
    Blood; 1998 Oct; 92(8):2712-8. PubMed ID: 9763554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWG.
    Kungwankiattichai S; Owattanapanich W; Rattanathammethee T; Rattarittamrong E; Chanswangphuwana C; Polprasert C; Limvorapitak W; Saengboon S; Niparuck P; Puavilai T; Julamanee J; Saelue P; Wanitpongpun C; Prayongratana K; Sriswasdi C; Nakhakes C
    Hematology; 2023 Dec; 28(1):2191462. PubMed ID: 36951362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study.
    Avvisati G; Lo Coco F; Diverio D; Falda M; Ferrara F; Lazzarino M; Russo D; Petti MC; Mandelli F
    Blood; 1996 Aug; 88(4):1390-8. PubMed ID: 8695858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation syndrome in promyelocytic leukemia: clinical presentation, pathogenesis and treatment.
    Rego EM; De Santis GC
    Mediterr J Hematol Infect Dis; 2011; 3(1):e2011048. PubMed ID: 22110898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-SARS-CoV2 antibody-mediated cytokine release syndrome in a patient with acute promyelocytic leukemia.
    Hegazy AN; Krönke J; Angermair S; Schwartz S; Weidinger C; Keller U; Treskatsch S; Siegmund B; Schneider T
    BMC Infect Dis; 2022 Jun; 22(1):537. PubMed ID: 35692034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report.
    Shenoy SM; Di Vitantonio T; Plitt A; Perez-Johnston R; Gutierrez J; Knorr DA; Stein EM; Liu JE; Feldman S
    Cardiooncology; 2021 Nov; 7(1):39. PubMed ID: 34814948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the management of coagulopathy in acute promyelocytic leukemia.
    Sanz MA; Montesinos P
    Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradycardia associated with Multisystem Inflammatory Syndrome in Children with COVID-19: a case series.
    Ciccarelli GP; Bruzzese E; Asile G; Vassallo E; Pierri L; De Lucia V; Guarino A; Lo Vecchio A
    Eur Heart J Case Rep; 2021 Dec; 5(12):ytab405. PubMed ID: 34993395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute promyelocytic leukemia: recent advances in diagnosis and management.
    Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
    Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).
    Inciardi RM; Lupi L; Zaccone G; Italia L; Raffo M; Tomasoni D; Cani DS; Cerini M; Farina D; Gavazzi E; Maroldi R; Adamo M; Ammirati E; Sinagra G; Lombardi CM; Metra M
    JAMA Cardiol; 2020 Jul; 5(7):819-824. PubMed ID: 32219357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical Analysis of Children with High-Risk Acute Promyelocytic Leukemia].
    Gao QL; LE SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):33-37. PubMed ID: 36765473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-transretinoic acid (ATRA) treatment-related pancarditis and severe pulmonary edema in a child with acute promyelocytic leukemia.
    Işık P; Çetin I; Tavil B; Azik F; Kara A; Yarali N; Tunc B
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):e346-8. PubMed ID: 20881874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions.
    Iyer SG; Elias L; Stanchina M; Watts J
    Front Oncol; 2022; 12():1062524. PubMed ID: 36741714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation Syndrome, a Side Effect From the Therapy of Acute Promyelocytic Leukemia.
    Reyhanoglu G; Hughes B; King KE; Cambridge R
    Cureus; 2020 Dec; 12(12):e12042. PubMed ID: 33447473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute promyelocytic leukemia: current strategies for the treatment of newly diagnosed disease.
    Sirulnik LA; Stone RM
    Clin Adv Hematol Oncol; 2005 May; 3(5):391-7, 429. PubMed ID: 16167012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.